feed,title,long_url,short_url
Benzinga,Another Competitor For Amgen As FDA Approves Mirati Therapeutics' KRAS Inhibitor For Lung Cancer Setting,https://benzinga.com/general/biotech/22/12/30054410/another-competitor-for-amgen-as-fda-approves-mirati-therapeutics-kras-inhibitor-for-lung-cancer-s,https://da.gd/jQIc
